Saturday, May 31, 2025

Latest

Aleafia Health Releases Fourth Quarter and Full Year Financial Results

Aleafia Health Inc (TSX: ALEF) has released its financial reports for the fourth quarter and fiscal year, reporting revenues of $6.0 million for the quarter while posting a net loss of $9.75 million.

In the fourth quarter 2019, Aleafia reported net revenues of $6.0 million, an increase of $1.07 million compared to the third quarter 2019, or 27%. However, the company reported a net loss of $9.75 million, going from a positive net income of $1.859 million in third quarter 2019, to a loss of $9.759 million by the fourth quarter 2019.

In terms of profitability, Aleafia had a gross margin of 43% in the third quarter of 2019, but in the fourth quarter 2019 that gross margin increased to 80%. Gross margin is the sales revenue remaining after direct production costs are deducted. A high level of gross margin indicates the company is retaining more capital per dollar incurred from sales.

On an annual basis, Aleafia had a net revenue increase of over 836% compared to fiscal year 2018, which had net revenues of $0.64 million. Net income as of December 31, 2018 was at a loss of $11.958 million – fast forward to December 31, 2019, the company is still operating at a loss, but that loss is lower by approximately 18.38%.

Lastly, Aleafia’s gross margin for December 31, 2018 was at 12%, which increased by 68% over the fiscal year.

Aleafia is a Canadian cannabis company focused on the production and sale of cannabis. The company also operates several medical clinics and education centers for cannabis.

Aleafia Health Inc is currently trading at $0.34 on the TSX.


Information for this briefing was found via Sedar and Aleafia Health Inc. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Alamos Gold Q1 Earnings: The Inside Scoop

Cerrado Gold Q4 Earnings: The Turnaround is Working

B2GOLD Q1 Earnings: Revenue Up, Production & Cash Flow Decline

Recommended

Canadian Copper: The $172M Combined Strategy PEA

ESGold Begins Concentration Tests Ahead Of First Production

Related News

Aleafia Health Revenues Crater 53.5% To $7.1 Million

It’s the tale of the Canadian public cannabis operator. Aleafia Health (TSX: AH) this morning...

Tuesday, May 11, 2021, 08:22:28 AM

Aleafia Health Launches First 2.0 Cannabis Products

Aleafia Health (TSX: AH) has finally entered the cannabis 2.0 market. The company issued a...

Tuesday, September 29, 2020, 10:07:50 AM

Aleafia Health Posts Revenues of $4.95 Million for Third Quarter

Aleafia Health (TSX: ALEF) reported its third quarter financial results this morning, posting net revenues...

Tuesday, November 12, 2019, 09:26:12 AM

Aleafia Health Announces $30 Million At The Market Financing

Aleafia Health (TSX: AH) this morning became the latest cannabis operator to announce an at-the-market...

Wednesday, June 9, 2021, 08:01:02 AM

Why Public Cannabis CFOs Need to Breakdown and Segment Their Accounts Receivables

Limited Disclosures Risk Signaling Poor Financial Health to Analysts and Investors The ‘accounts receivable to...

Sunday, November 24, 2019, 08:00:42 AM